Tuoxin Pharmaceutical has announced plans to inject an additional 10 million yuan of its own funds into Jiangsu Jinshan Biotechnology Co., Ltd. (hereinafter referred to as "Jinshan Biotech"). Upon the successful completion of this transaction, Tuoxin Pharmaceutical will acquire a 1.75% equity stake in Jinshan Biotech. Jinshan Biotech has pioneered the production of high-purity ergothioneine, with its product line encompassing skincare products, oral capsules, and eye wash solutions, among others.